Live Breaking News & Updates on Pharma outlook 2024
Stay updated with breaking news from Pharma outlook 2024. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In today's trade, Lupin's shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its 'buy' recommendation.